No Data
No Data
I-Mab Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
Express News | I-Mab Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
I-Mab Announces Receipt Of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
I-Mab Announces Accelerated Givastomig Phase 1b Study Progress
Express News | I-Mab: Phase 1B Dose Escalation Data Expected to Be Presented in 2H 2025
Express News | I-Mab Announces Accelerated Givastomig Phase 1B Study Progress
Unlock the Full List